3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors
申请人:SmithKline Beecham Corporation
公开号:US07053099B1
公开(公告)日:2006-05-30
Novel substituted quinazoline compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
小说替代喹唑啉化合物和组合物,用于治疗CSBP/p38激酶抑制剂。
EP1235814A4
申请人:——
公开号:EP1235814A4
公开(公告)日:2003-05-28
US7053099B1
申请人:——
公开号:US7053099B1
公开(公告)日:2006-05-30
[EN] 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS<br/>[FR] COMPOSES DE 3,4-DIHYDRO-(1H)QUINAZOLINE-2-ONE UTILISES COMME INHIBITEURS DE LA KINASE CSBP/p38
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2001038312A1
公开(公告)日:2001-05-31
Novel substituted quinazoline compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS